Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sintx Technologies (SINT) Change in Acquisitions & Divestments (2013 - 2021)

Sintx Technologies' quarterly Change in Acquisitions & Divestments came in at $1.4 million in Q2 2021, up 158.25% year-on-year from $527000.0 in Q2 2020, and up 133.45% quarter-over-quarter from $583000.0 in Q1 2021.

Sintx Technologies has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $1.4 million in Q2 2021.

  • For the quarter ending Q2 2021, Change in Acquisitions & Divestments rose 158.25% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2021 stood at $1.9 million (down 7.91% YoY), and the FY2021 full-year result was $1.9 million, down 7.91% from the prior year.
  • Change in Acquisitions & Divestments for Q2 2021 stood at $1.4 million, up from $583000.0 in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $1.4 million in Q2 2021, with the low at $279000.0 in Q2 2019.
  • Average Change in Acquisitions & Divestments over 3 years is $558300.0, with a median of $472000.0 recorded in 2019.
  • Year-over-year, Change in Acquisitions & Divestments increased 0.24% in 2020 and surged 158.25% in 2021.
  • Tracing SINT's Change in Acquisitions & Divestments over 3 years: stood at $417000.0 in 2019, then soared by 39.81% to $583000.0 in 2020, then soared by 133.45% to $1.4 million in 2021.
  • The last three Change in Acquisitions & Divestments figures came in at $1.4 million (Q2 2021), $583000.0 (Q1 2021), and $583000.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 1.36 Mn
Jun 30, 2021 1.36 Mn
Mar 31, 2021 583,000.00
Mar 31, 2021 583,000.00
Dec 31, 2020 583,000.00
Dec 31, 2020 583,000.00
Sep 30, 2020 584,000.00
Sep 30, 2020 584,000.00
Jun 30, 2020 527,000.00
Jun 30, 2020 527,000.00
Mar 31, 2020 417,000.00
Mar 31, 2020 417,000.00
Dec 31, 2019 417,000.00
Dec 31, 2019 417,000.00
Sep 30, 2019 416,000.00
Sep 30, 2019 416,000.00
Jun 30, 2019 279,000.00
Jun 30, 2019 279,000.00
Mar 31, 2019 416,000.00
Mar 31, 2019 416,000.00
Sep 30, 2013 1.28 Mn
Sep 30, 2013 1.28 Mn
Jun 30, 2013 942,000.00
Jun 30, 2013 942,000.00
Mar 31, 2013 463,000.00
Mar 31, 2013 463,000.00